Laura P. Knoll

Laura Knoll concentrates her practice in the areas of mergers and acquisitions and general corporate matters, advising public and private companies in a broad range of transactional and corporate contexts, including acquisitions and divestitures, leveraged buyouts, securities law compliance, shareholder activism defense and corporate governance.

Ms. Knoll was recognized in Chambers USA 2018, named in The Legal 500 U.S. and received the Emerging Leaders Award from The M&A Advisor in 2016. Some of her significant representations include:

• United Natural Foods in its pending acquisition of SUPERVALU for $2.9 billion, including assumption of outstanding debt and liabilities;
• Hasbro in its $522 million acquisition of Saban Brands’ Power Rangers and other entertainment assets;
• Kelso & Company and affiliates of Blue Wolf Capital Partners in connection with the acquisition of Jordan Health Services from Palladium Equity Partners, and Kelso in connection with the concurrent merger of Jordan Health Services with Great Lakes Caring and National Home Health Care under a combined entity jointly owned with affiliates of Blue Wolf;
• Ultragenyx Pharmaceutical in its successful topping bid for Dimension Therapeutics;
• Qlik Technologies Inc. in its $3 billion acquisition by Thoma Bravo, LLC;
• Banco BTG Pactual S.A. in its $1.7 billion acquisition of BSI SA from Assicurazioni Generali S.p.A. and sale of BSI SA to EFG International AG;
• Dendreon Corporation in its Chapter 11 filing and proposed restructuring of $620 million of convertible notes and in its sale of assets to Valeant Pharmaceuticals International, Inc. for $495 million;

Education:

• J.D., Harvard Law School, 2005
• B.A., Harvard University, Harvard College, 2002

Admissions:

• Massachusetts
• New York